Samson, Emma Linda L.
HRN: 16-37-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/02/2023
02/09/2023
IV
600mg
Q8
Cellulitis L Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes